NASHVILLE, Tenn., April 22, 2025 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) plans to release its first quarter 2025 financial results after the market closes on Tuesday, May 6, 2025. The Company also plans to discuss the results on a conference call scheduled for Wednesday, May 7, 2025, at 9:00 a.m. (ET).
BROOKDALE SENIOR LIVING - EARNINGS CALL
Date: Wednesday, May 7, 2025
Time: 9:00 a.m. (ET) / 8:00 a.m. (CT)
brookdaleinvestors.com
Call Within US: +1 (800) 715-9871
Call Outside US: +1 (646) 307-1963
Conference ID: 1482282
A webcast of the conference call will be available to the public on a listen-only basis at brookdaleinvestors.com. Please allow extra time before the call to download the necessary software required to listen to the internet broadcast.
For those who cannot listen to the live call, a replay of the webcast will be available until 11:59 p.m. (ET) on May 14, 2025 by dialing +1 (800) 770-2030 (from within the U.S. & Canada) or all other locations +1 (609) 800-9909 and entering Playback ID: 1482282#.
About Brookdale Senior Living
Brookdale Senior Living Inc. is the nation's premier operator of senior living communities. With 647 communities across 41 states and the ability to serve approximately 58,000 residents, as of March 31, 2025, Brookdale is committed to its mission of enriching the lives of seniors through compassionate care, clinical expertise, and exceptional service. The Company, through its affiliates, operates independent living, assisted living, memory care, and continuing care retirement communities, offering tailored solutions that help empower seniors to live with dignity, connection, and purpose. Leveraging deep expertise in healthcare, hospitality, and real estate, Brookdale creates opportunities for wellness, personal growth, and meaningful relationships in settings that feel like home. Guided by its four cornerstones of passion, courage, partnership, and trust, Brookdale is committed to delivering exceptional value and redefining senior living for a brighter, healthier future. Brookdale's stock trades on the New York Stock Exchange under the ticker symbol BKD. For more information, visit brookdale.com or connect with Brookdale on Facebook or YouTube.
Last Trade: | US$6.58 |
Daily Change: | 0.01 0.15 |
Daily Volume: | 2,256,810 |
Market Cap: | US$1.310B |
April 08, 2025 February 24, 2025 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MOREImmix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREEnd of content
No more pages to load